ADHD Telehealth in California: 2026 Laws, Platforms, and Medi-Cal Coverage

Yes – California residents can be evaluated and treated for ADHD fully online, including stimulant prescriptions where clinically appropriate. California imposes no state ban on telehealth controlled-substance prescribing; care proceeds under federal flexibilities through December 31, 2026, with California adding procedural safeguards – a mandatory CURES database check before your first prescription and at least every six months after (Health & Safety Code § 11165.4), plus mandatory e-prescribing.

That combination makes California one of the most workable states in the country for online ADHD treatment. But “no state ban” does not mean “no rules.” California layers its own procedural requirements on top of federal telehealth law, and those requirements shape what your appointments look like, how often you will be re-evaluated, and where your medication can actually be filled. This guide covers the 2026 legal picture in California, the telehealth platforms that serve the state, the California-specific rules most patients never hear about until they hit them, and how Medi-Cal coverage works for online ADHD care.

Is ADHD telehealth treatment legal in California?

Yes. No California statute restricts Schedule II teleprescribing beyond what federal law already requires. While states like Georgia and Texas have added their own layers of restriction on controlled-substance telehealth, California has chosen not to, so the legality of your online ADHD prescription in California rests on the federal flexibilities that run through December 31, 2026.

California law affirmatively supports telehealth prescribing rather than merely tolerating it. Business and Professions Code § 2242 requires an “appropriate prior examination” before any prescription, and AB 1264 (2019) clarified that a telehealth visit satisfies that requirement. The one condition: the standard of care delivered over video must equal what you would receive in person. In practice, that means a California clinician evaluating you for ADHD online must take a real diagnostic history, screen for conditions that mimic or complicate ADHD, and exercise independent clinical judgment about whether medication is appropriate. A legitimate platform may decline to prescribe, recommend a non-stimulant first, or request prior records, and that is the law working as intended.

The California-specific mechanism you will actually feel is CURES, the state’s prescription drug monitoring database. Under Health and Safety Code § 11165.4, your prescriber must consult your CURES report, with records no more than 24 hours old, before first prescribing any Schedule II-IV medication, and at least every six months for as long as the prescription continues. One correction worth making explicitly: some articles still claim California requires a CURES check “every 4 months.” That was the interval before AB 528 took effect; the current statute says at least every six months. The practical meaning for patients: expect renewal evaluations at least twice a year.

Finally, California has required e-prescribing of controlled substances since January 1, 2022 (AB 2789), so your stimulant prescription travels electronically from your clinician directly to one pharmacy. More on why that matters below.

Which ADHD telehealth platforms serve California?

Every major ADHD telehealth platform we cover serves California, and none of them applies state-specific stimulant restrictions here beyond Talkspace’s own platform-wide policy. That is unusual; in most states at least one platform carves out the state or limits prescribing. Here is how the six compare for California patients in 2026.

California is the least-restricted state we cover, which changes how you should choose. In stricter states, the decision tree starts with “which platforms can even prescribe here.” In California, all six operate, so the decision comes down to care model, cost, and insurance fit. If you want insurance billing with employed psychiatrists, Talkiatry and LifeStance are built for that. If you are paying cash, Klarity’s marketplace model tends to be the least expensive ongoing option, while Circle Medical pairs cash visits with primary-care continuity. ADHD Online suits people who want a formal diagnostic assessment they can carry to another prescriber. Talkspace is the outlier: it serves California but, by its own platform policy, prescribes non-stimulant ADHD medications only.

California-specific rules that shape your care

The CURES check sets your renewal rhythm

Because Health and Safety Code § 11165.4 requires a CURES consultation at least every six months while a Schedule II-IV prescription continues, online ADHD treatment in California is never a one-and-done evaluation. Plan on at least two renewal touchpoints per year where your prescriber reviews your CURES report alongside how you are responding to medication. Most platforms schedule follow-ups more often than that, especially during dose titration, but the six-month CURES floor is the legal minimum that keeps your prescription valid. If a platform’s renewal cadence feels like friction, it is actually compliance: a prescriber who never re-checks CURES is the red flag, not the one who does.

Nurse practitioners can prescribe Schedule II in California

California permits nurse practitioners to prescribe Schedule II medications, including stimulants, provided they hold a furnishing number and their own DEA registration. This matters more than it sounds. In states with physician-only stimulant rules, telehealth platforms face a supply bottleneck because every prescription must route through an MD or DO. California has no such bottleneck, which is why marketplace platforms like Klarity have noticeably deeper provider availability in California than in physician-only states. For patients, that translates into shorter waits for appointments and more choice among prescribers, while the clinical bar for prescribing remains the same regardless of the clinician’s license type.

E-prescribing plus stimulant shortages: pick your pharmacy deliberately

Since January 1, 2022, AB 2789 has required that controlled-substance prescriptions in California be transmitted electronically, directly from prescriber to pharmacy. There is no paper script to carry around. That works smoothly until it collides with the ongoing stimulant shortages: if your chosen pharmacy is out of stock, a Schedule II e-prescription cannot simply be transferred pharmacy-to-pharmacy the way a routine medication can. In most cases your prescriber must cancel and reissue the prescription to a new location.

The practical strategy: choose your pharmacy before your appointment, not during it. Call ahead and ask whether they currently stock your likely medication and dose, consider an independent pharmacy if the big chains near you are persistently short, and tell your prescriber during the visit if you have a backup pharmacy in mind. A few minutes of legwork up front prevents a multi-day reissue cycle later.

Does Medi-Cal cover ADHD telehealth?

Yes. Medi-Cal covers telehealth psychiatry at parity with in-person care, meaning a covered ADHD evaluation or medication-management visit delivered by video is reimbursed the same as the identical visit in a clinic. For Medi-Cal members in California, the telehealth visit itself is not a coverage obstacle.

One Medi-Cal nuance is worth knowing. The Department of Health Care Services classifies behavioral health as a “sensitive service,” and under policy phased in beginning January 1, 2024, providers who offer those services by audio-only telephone must also offer a video option. You cannot be limited to phone-only ADHD care if you want video, and the modality choice is ultimately yours and your clinician’s. The details are laid out in the DHCS telehealth FAQ.

The harder question for Medi-Cal members is network, not coverage. Most of the national ADHD platforms in the table above bill commercial insurance rather than Medi-Cal, so Medi-Cal members typically access telehealth psychiatry through their managed care plan’s behavioral health network; call the member services number on your card and ask specifically for telehealth psychiatry providers who treat ADHD. If you have commercial insurance instead, see our guide to ADHD telehealth that takes insurance for plan-by-plan platform fit.

Frequently asked questions

Can doctors prescribe Adderall through telehealth in California?

Yes, where clinically appropriate. California imposes no state ban on telehealth controlled-substance prescribing, so under the federal flexibilities in effect through December 31, 2026, a California-licensed clinician can evaluate you by video and prescribe Adderall or another stimulant if the examination supports an ADHD diagnosis and medication is the right fit. The prescriber must check your CURES report first and transmit the prescription electronically. Prescribing is always a clinical-judgment decision; a clinician may recommend a non-stimulant or decline to prescribe based on your evaluation.

How often is the CURES database checked?

Under Health and Safety Code § 11165.4, your prescriber must consult CURES, with data no more than 24 hours old, before your first prescription of any Schedule II-IV medication, and then at least every six months for as long as the prescription continues. Some older articles say “every four months”; that was the interval before AB 528 amended the statute, and the current requirement is six months. Expect at least two renewal evaluations per year.

Do I ever need an in-person visit for ADHD medication in California?

Under the current federal flexibilities, which run through December 31, 2026, no in-person visit is legally required, and California law treats a telehealth visit as satisfying the state’s prior-examination requirement under AB 1264. That said, your clinician can require an in-person exam, prior records, or other evaluation steps based on clinical judgment, and future federal rules could reintroduce in-person elements after the flexibilities end.

Does Medi-Cal cover online ADHD treatment?

Yes. Medi-Cal covers telehealth psychiatry at parity with in-person care, so a covered ADHD visit by video is reimbursed the same as the equivalent office visit. Because behavioral health is a DHCS “sensitive service,” providers offering audio-only care must also offer video. The main constraint is network: most national ADHD platforms bill commercial insurance, so Medi-Cal members usually access telehealth ADHD care through their managed care plan’s behavioral health network.

Can nurse practitioners prescribe stimulants in California?

Yes. California nurse practitioners with a furnishing number and their own DEA registration can prescribe Schedule II medications, including ADHD stimulants. There is no physician-only bottleneck like the ones in Georgia or Texas, which is one reason telehealth platforms, especially marketplace models like Klarity, maintain deeper provider supply in California than in more restrictive states. NPs follow the same CURES and e-prescribing requirements as physicians.

What changes after December 31, 2026?

December 31, 2026 is when the federal telehealth controlled-substance flexibilities are currently set to expire. If they lapse without an extension or a replacement framework, new federal requirements could apply to telehealth stimulant prescribing nationwide, including in California. California’s own rules, including the CURES check, mandatory e-prescribing, and AB 1264’s telehealth examination standard, are permanent state law and do not expire. If you are an established telehealth patient, watch for communications from your platform as the date approaches.

California gives you more viable ADHD telehealth options than any other state we cover, which means the real work is matching a platform to your insurance, budget, and care preferences rather than navigating legal workarounds. To see current pricing, insurance acceptance, and prescribing models in one place, compare ADHD telehealth providers side by side.